BDX vs WST — Key Metrics

Metric BDX (BECTON DICKINSON & CO) WST (WEST PHARMACEUTICAL SERVICES INC)
Price216.08404.02
Market Cap58.86 Billion28.14 Billion
P/E (TTM)65.0845.04
P/B (Quarterly)1.9759.779
P/S (TTM)2.828.29
Net Profit Margin (TTM)4.518.8
Gross Margin (TTM)46.437.6
ROE (TTM)3.821.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

BECTON DICKINSON & CO
vs
 
WEST PHARMACEUTICAL SERVICES INC
 
BECTON DICKINSON & CO
vs
 
WEST PHARMACEUTICAL SERVICES INC
Performance Comparison
AI Model Recommendation
BDX · BECTON DICKINSON & CO
hmmm...
WST · WEST PHARMACEUTICAL SERVICES INC

Greatly Underperform

-95
UnderperformOutperform
Recommendation Summary

BDX is not scored by the AI model, which covers non-financial S&P 500 companies (banks, insurers and asset managers report on a different basis), so there is no recommendation for this pair.

Financial Metrics
Prices delayed ~15 min
BDX Metrics WST
$216.08 Price $404.02
— Market Capitalization —
65.08 Price to Earnings Ratio 45.04
2.82 Price to Sales 8.29
23.25 Price to FCF Ratio 48.5
6.08 Price to Gross Profit 22.04
51.86 Price to R&D 372.28
7.23 Price to Current Assets 15.49

BDX vs WST at a glance

Becton Dickinson & CO (BDX) and West Pharmaceutical Services INC (WST) are both Medical Instruments & Supplies companies in the Healthcare sector. BDX is the larger, at $58.9 billion in market value against $28.1 billion for WST, about 2.1 times the size.

On trailing-twelve-month figures, BDX trades at 65.1 times trailing earnings and WST at 45.0; net profit margins are 4.5% and 18.8%.